Clinician-guided GLP-1 weight-management evaluation with programs starting at $299/mo. Compounded drugs, when considered for a patient-specific need, are not FDA-approved.

FDA-approved prescription products containing semaglutide or tirzepatide have indication-specific evidence for chronic weight management or type 2 diabetes. Results depend on the product, dose, studied population, adherence, and ongoing treatment.

Compounded drugs are not FDA-approved. FDA does not review a compounded drug for safety, effectiveness, or quality before it is marketed, and outcomes from trials of FDA-approved products should not be used to predict results from a compounded product.

LifeSpann begins with medical history, current medications, vital signs, and appropriate laboratory review. The clinician determines whether an FDA-approved medication is appropriate and whether any patient-specific alternative is lawful and medically necessary.

Dosing and follow-up are individualized to the prescribed product and its labeling. Monitoring includes response, side effects, nutrition, body composition, and whether treatment should continue, change, or stop.

How It Works

GLP-1 receptor agonist mechanism of action

GLP-1 receptor agonists can affect appetite signaling, gastric emptying, and glucose-dependent insulin release. Clinical effects and risks depend on the specific prescribed product and patient.

Clinician-guided weight management monitoring timeline

Response is assessed over time using the prescribed product's instructions, side-effect review, nutrition, activity, and appropriate clinical monitoring.

You May Benefit If You Experience

BMI of 27 or higher with a weight-related health condition (or BMI of 30 or higher)
Failed to achieve lasting results with diet and exercise alone
Insulin resistance, pre-diabetes, or metabolic syndrome
Persistent food cravings or difficulty controlling portions
Weight regain after previous successful weight loss
Desire for a medically supervised, evidence-based approach

Your Treatment Process

01

Health Assessment

Review medical history, current medications, vital signs, relevant labs, contraindications, and risks to assess whether treatment is appropriate.

02

Medication Selection

Identify whether medication is appropriate and, if so, which prescribed product fits. FDA-approved and compounded products are not interchangeable; compounded drugs are not FDA-approved.

03

Dose Planning

Follow the instructions for the specific prescribed product. Dose and titration are individualized rather than inferred from a different product.

04

Monthly Check-Ins

Weight, vitals, measurements, symptom review, and dose adjustments to keep you on track.

05

Maintenance Planning

As you approach your goal, we develop a transition plan — whether continuing at a maintenance dose or tapering.

Transparent Pricing

Semaglutide Evaluation $299/mo program Published monthly cash program price. Inclusions vary by the exact prescribed product; staff confirms medication, visits, labs, supplies, and shipping costs before enrollment.
Tirzepatide Evaluation $399/mo program Published monthly cash program price. Inclusions vary by the exact prescribed product; staff confirms medication, visits, labs, supplies, and shipping costs before enrollment.

Ready to Get Started?

Use this page as a starting point for a provider conversation about fit, safety questions, and next steps.

(480) 351-7151 Coverage varies by plan and service.

Cancellation Policy: A $50 non-refundable deposit is required to confirm your appointment for all new patient consultations and procedures — our front desk will reach out to collect it after you book. The deposit is applied toward your visit cost. We require at least 24 hours' notice for cancellations or changes. No-shows or late cancellations will forfeit the deposit. A $75 fee applies for physical exam appointments not canceled with 24 hours' notice. By booking, you agree to these terms.

Business hours: Mon–Thu 8am–6pm · Fri 8am–12pm